Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Q2 2024 Earnings Conference Call August 8, 2024 1:00 PM ET
Company Participants
Lukas Hartwich - Senior Vice President, Finance
Rick Matros - Chief Executive Officer, President & Chair of the Board
Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President
Michael Costa - Chief Financial Officer
Conference Call Participants
Elmer Chang - Scotiabank
Austin Wurschmidt - KeyBanc Capital Markets
Joshua Dennerlein - Bank of America
Michael Griffin - Citigroup
Vikram Malhotra - Mizuho Securities
John Pawlowski - Wells Fargo
Rich Anderson - Wedbush Securities
Michael Stroyeck - Green Street Advisors, LLC
Alec Feygin - Baird Equity Research
Operator
Good day, everyone. My name is Christina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Second Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be question-and-answer session. [Operator Instructions]
I would now like to turn the call over to Lukas Hartwich, SVP of Finance. Please go ahead, Mr. Hartwich.
Lukas Hartwich
Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2024 and our expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans.
These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2023, as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements that reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid.
In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the Financials page of the Investors section of our website at sabrahealth.com. Our Form 10-Q, earnings release and supplement can also be accessed in the Investors section of our website.